Page last updated: 2024-10-26

doxepin and Lymphoma

doxepin has been researched along with Lymphoma in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research Excerpts

ExcerptRelevanceReference
" The purpose of this study was to assess the impact of doxepin oral rinse in the management of oral mucosal pain in cancer patients."7.71Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. ( Allison, C; Epstein, JB; Epstein, MS; Le, ND; Oien, H; Truelove, EL, 2001)
" The purpose of this study was to assess the impact of doxepin oral rinse in the management of oral mucosal pain in cancer patients."3.71Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. ( Allison, C; Epstein, JB; Epstein, MS; Le, ND; Oien, H; Truelove, EL, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Epstein, JB1
Truelove, EL1
Oien, H1
Allison, C1
Le, ND1
Epstein, MS1

Other Studies

1 other study available for doxepin and Lymphoma

ArticleYear
Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy.
    Oral oncology, 2001, Volume: 37, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analgesics; Doxepin; Female; Head and Neck Neoplasms; Humans; Leukem

2001